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Aim of this study was to derive new lung function reference equations and compare the
predicted values with those from three sets of existing reference equations: one derived
from a Northern Italy population and the two others widely used in European (ECCS) and
American (NHANES III) clinical practice.
Reference equations for flow-volume curve indexes and VC were derived on 497 normal
subjects, aged 8–74, from the epidemiological survey in Pisa, Central Italy (1991–1993). By
applying natural cubic splines, one single smooth and continuous equation for the entire
age range was provided for each index, separately by gender.
Along with age and height, reference values also depended on BMI. Differences among the
four reference equations for FEV1, FVC, VC were quantified for average subjects. The
magnitude largely varied over the age range in both genders, reaching up to half litre of air
volume at specific ages. Age-gender-specific prevalence rates of airway obstruction, as
defined by the ERS criterion, largely varied by applying the considered equations, the
differences ranging from 3% to 28%.
The observed discrepancies confirm that reference equations should be derived from a
population most similar to that for which the equations are to be used and based on
measurements obtained by the same instrument and testing procedures, in order toElsevier Ltd. All rights reserved.
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Spirometry reference equations from central Italy 815minimize technical variability in lung function both for clinical and epidemiological
purposes.
& 2006 Elsevier Ltd. All rights reserved.Introduction
It is known that the variation in reference equations
between studies can be quite considerable. In 1983, the
European Community for Coal and Steel (ECCS)1 derived
summary reference equations by pooling existing equations
from several different populations published in the previous
three decades. The authors stated that no reference
equation was superior to the other, and envisaged the use
of the summary equations in all laboratories, as they
described an overall mean of data in the literature.
Conversely, in an official document of the American Thoracic
Society (ATS) published in 1991,2 it was stated that when
selecting reference values for lung function testing ‘‘neither
is as important as the choice of a reference population that
(1) provides an appropriate comparison for the subjects to
be evaluated, and (2) is based on measurements made with
instruments and methods comparable to those used in the
laboratory for which reference values are being selected’’.
The same standpoint has been stated in the official
document published in 2005 by the ATS/European Respira-
tory Society (ERS) Task Force on the standardization of lung
function testing.3
In the last 15 yr, publication of spirometric reference
values published from a variety of ethnic/race groups and
age ranges has continuously increased, demonstrating the
interest of world-wide researchers in deriving and using
spirometry reference equations.4–13 We previously derived
smooth continuous reference equations from the Po river
delta study in Northern Italy14 (‘Pistelli 2000’).
In the USA, the National Health and Nutrition Examination
Survey (NHANES) III reference equations (‘Hankinson 1999’)7
are recommended for individuals aged 8–80 yr.3 In Europe,
the ECCS summary equations (‘ECCS 1983’)1 are often used
for individuals 18–70 yr but they are not currently recom-
mended.3 Several reports have demonstrated that ‘ECCS
1983’ provide lower predicted values than more recent
equations from different European countries.6,8,11,13,15
Prevalence rates of airway obstruction vary largely in
different studies, ranging from 0.2% to 18.3%.16 The use of
different criteria of airway obstruction may partly explain
the variability of prevalence rates, as originally reported by
us17 and confirmed by Celli et al.18 on the NHANES III data.
An additional, not yet explored, source of variability is
related to the use of different sets of reference equations,
when they are applied for diagnosing airway obstruction.
This is the case for the criterion based on the reduction of
forced expiratory volume in 1 s (FEV1)/slow vital capacity
(VC) ratio (FEV1/VC) with respect to its ‘‘lower normal
limit’’. This criterion was first recommended by the ATS in
19912 and by the ERS in 1995,19 and confirmed in 2005 by the
ATS/ERS Task Force on the standardisation of lung function
testing.3
The aim of this paper was to derive new lung function
reference equations from the sample of the second cross-sectional survey of the Pisa study in Central Italy, and to
compare them with those of ‘Pistelli 2000’14—from a
different Italian population sample—and the two most
world-wide used ‘ECCS 1983’1 and ‘Hankinson 1999’.7 The
implications of using different reference equations to
compute prevalence rates of airway obstruction were also
exemplified.Material and methods
Reference equations were derived on 497 ‘‘normal’’ subjects
from the second cross-sectional survey in Pisa, Central
Italy20 (1991–1993, urban area, n ¼ 2841, males 45%, age
range 8–97 yr).
The ‘‘normal’’ subjects were selected by excluding those
who reported: past or current smoking history, including
occasional (n ¼ 1397 remaining subjects); occupational
exposure to noxious agents 45 yr (n ¼ 1308 remaining
subjects); respiratory symptoms, i.e. cough, phlegm,
wheeze, effort dyspnea, attacks of breathlessness with
wheeze or whistles (n ¼ 779 remaining subjects); medical
diagnosis of emphysema, asthma or chronic bronchitis
(n ¼ 772 remaining subjects); chest injuries (n ¼ 754 re-
maining subjects); heart troubles (n ¼ 663 remaining sub-
jects). Further, were excluded those who did not meet
measurement protocol (n ¼ 497 remaining subjects). Data
were obtained by the interviewer-administered CNR-ques-
tionnaire.20
A water-sealed spirometer (Baires, Biomedin, Padua,
Italy) was used for measuring flow and volume. The same
instrument was utilized in the European Community Re-
spiratory Health Survey.6 This instrument has a frequency
response of 30Hz and the linearity of the transducer of
position is 0.25%. The day-by-day variation in calibration
observed over time for this instrument ranges between 0%
and 1.8% with a mean error of 0.4%. Volume calibration was
performed daily by using a 3-l standard syringe. A team of
six nurses/technicians used two instruments of the same
type in two different locations. All the nurses/technicians
received the same training for performing lung function
tests. Instrument characteristics and measurement protocol
fulfilled the 1987 American Thoracic Society recommenda-
tions.21 At least two trials were repeated to obtain a
satisfactory VC value. The highest VC was used for analyses.
Up to eight-forced vital capacity (FVC) maneuvers were
performed to obtain at least three acceptable trials. The
two largest FVC and FEV1 values should not vary by more
than 5%. The largest FVC and FEV1 values were selected,
regardless of the maneuver. From the maneuver with the
largest sum FVC+FEV1 the following flows were selected:
peak expiratory flow (PEF); forced expiratory flow between
25% and 75% of FVC (FEF2575%); maximal expiratory flow at
50% (MEF50%) and 75% (MEF75%) of FVC. As a further quality
criterion, the largest FVC and the largest VC should not vary
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F. Pistelli et al.816by more than 5%. In the present study, VCmax was also
computed as the largest value of VC and FVC for each
individual.
Height (cm) and weight (kg) were measured in standing
position without shoes in subjects wearing clothes. Age at
last birthday was recorded. Body mass index (BMI) was
computed as weight/height-squared, expressed in kg/m-
squared.Statistical analysis
For each index, one single smooth continuous equation was
derived for each gender.14 Independent variables were age,
height and BMI. The non-linear relationship between age
and lung function indexes was modelled by natural cubic
splines for all indexes, except for FEV1/FVC and FEV1/VC
whose dependence on age appeared to be linear.
Natural cubic splines provide smooth curves with con-
tinuous first and second derivatives over the whole age
range. In the extreme intervals, where fewer observations
are available, natural cubic splines are constrained to be
linear. Details about computation of the predicted values
are reported in the Appendix. The two breakpoints used for
the different indexes were chosen, based on a grid search,
as those which maximized the goodness-of-fit as measured
by R2. BMI and height showed a curvilinear relationship with
all indexes that was adequately fit by second-order
polynomials. For all the indexes the lower normal limit
was expressed by the ‘‘normal fifth percentile’’, which was
defined as the percent predicted value below which fell 5%
of the sample of normal subjects.2,14 Exact binomial
confidence intervals about the point estimate for the
‘‘normal fifth percentile’’ were also provided. All pair-wise
interactions were not significant at 0.05-level and kept out
of the models.Table 1 Descriptive statistics of the normal subjects used to d
Males (n ¼ 196)
Mean SD Min M
Age (yr)a 26.89 15.49 8
BMI (kg/m2) 23.19 3.74 14.57
Height (cm)a 171.63 11.85 125 1
Weight (kg)a 69.10 15.32 25 1
VC (l)a 4.78 1.24 1.66
FVC (l)a 4.92 1.20 1.65
VCmax (l)
a,b 4.95 1.20 1.66
FEV1 (l)
a 4.16 0.99 1.46
FEV1/VC 0.86 0.07 0.65
FEV1/FVC 0.85 0.07 0.67
FEF25–75 (l/s)a 4.68 1.43 1.40
PEF (l/s)a 8.33 2.03 2.65
MEF50 (l/s)a 5.43 1.56 1.96
MEF75 (l/s)a 2.42 1.07 0.50
aPo0.05 by Wilcoxon rank-sum test.
bVCmax is defined for each individual as the maximum value betwePrediction plots of FEV1 versus age are shown for
‘‘average’’ subjects. Since, at any given age, height and
BMI vary across subjects, height and BMI were averaged by
using Lowess smoothing (robust locally weighted regres-
sions) of height and BMI on age.22 Prediction plots of FEV1
versus height and BMI were analogously computed.
We performed an internal cross-validation of the pre-
dicted values, separately in males and females. The sample
of ‘‘normal’’ subjects was split in 10 equally sized sub-
samples at random and new regression models were
estimated by using data from nine of the ten sub-samples
(90% of the entire dataset), leaving one sub-sample out (10%
of the entire dataset). The differences and the ratios
between the observed values and the predicted values were
calculated for the sub-sample that was left out (‘validation
sample’). Such a procedure was repeated ten times, one for
each sub-sample in turn.
Bland Altman plots of FEV1 and FVC predicted differences
by means, for the new equations and ‘Pistelli 2000’, ‘ECCS
1983’, and ‘Hankinson 1999’ were included.23
All statistical analyses were performed in Stata software
(Stata Corporation, College Station, TX, USA).Results
Derivation of new reference equations
Table 1 shows the characteristics of the sample of ‘‘normal’’
subjects used to derive the reference equations. Males were
on the average younger, taller, heavier and had larger
respiratory volumes and flows than females: differences
were statistically significant. On the contrary, the average
ratios FEV1/VC and FEV1/FVC were similar as was the case
for BMI. In both genders, FVC mean values were slightlyerive the new reference equations.
Females (n ¼ 301)
ax Mean SD Min Max
70 36.94 19.25 8 74
34.26 23.62 4.14 14.72 39.74
95 160.56 7.46 125 181
00 60.99 11.42 25 103
7.77 3.48 0.66 1.43 5.40
7.92 3.54 0.65 1.49 5.41
7.92 3.56 0.65 1.49 5.41
6.27 2.98 0.62 1.36 4.85
0.98 0.85 0.08 0.62 0.98
0.98 0.84 0.07 0.62 0.98
8.74 3.37 1.09 0.70 5.93
12.79 5.94 1.23 3.09 8.99
10.00 3.98 1.06 1.38 6.56
6.32 1.69 0.87 0.18 3.99
en VC and FVC.
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with respect to FVC mean values.
Table 2 reports the estimated coefficients for VC, FEV1, FVC,
FEV1/FVC, FEV1/VC from the new equations. In both sexes,
predicted values of VC, FEV1 and FVC showed a parabolic
nonlinear relationship with BMI and height and a more complex
nonlinear association with age. For the two ratios, age was a
significant linear predictor. Nearly all the estimated coeffi-
cients were statistically significant. The ‘‘normal fifth percen-
tile’’ values ranged from 82% to 90% predicted.
The nonlinear relationships between predicted values and
predictors are shown in Fig. 1 for FEV1. Predicted values
steeply increased with age until about 25 yr in males (Fig.
1a) and 20 yr in females (Fig. 1d), and steadily decreased
afterwards in a continuous and smooth fashion. Further-
more, FEV1 predicted values increased according to a
slightly convex parabolic trend as height increased both in
males (Fig. 1b) and females (Fig. 1e), while they slowly
increased up to a BMI value of about 24 kg/m2 in males
(Fig. 1c) and about 20 kg/m2 in females (Fig. 1f) and
decreased afterwards.
The estimated coefficients for the remaining spirometric
indexes are shown in Table 3. Except for age, the
associations with the independent variables were seldom
statistically significant, largely due to the high variability ofTable 2 Estimated coefficients associated with the indepen
separately for the two genders.
VC FEV1
Males
Constant 11.1943 5.43862ns
BMI 0.2310701 0.1918785
BMI2 0.0037232ns 0.0034633
Height 0.2087963 0.1241893
Height2 0.0008009 0.0005119
Age 0.1621762 0.1603364
Spline1(age) 0.0010401 0.0011688
Spline2(age) 0.0007796 0.0008873
(breakpoints) (21, 25) (21, 25)
Normal fifth percentile
(% of predicted) 82 83
[95% confidence interval] [80,84] [79,85]
Females
Constant 4.702777 ns 2.714397ns
BMI 0.1784679 0.0852553
BMI2 0.0032607 0.0015578
Height 0.1116252 ns 0.0710514n
Height2 0.0004762 0.0003158ns
Age 0.1752335 0.2189869
Spline1(age) 0.0018615 0.0025242
Spline2(age) 0.0009931 0.0011336
(breakpoints) (14, 19) (13, 19)
Normal fifth percentile
(% of predicted) 83 83
[95% confidence interval] [81,85] [81,86]
For a numerical example of the computation of predicted values, se
nsNon-significant: P40.10 by Wald test.respiratory flows measurements. However, BMI and height
showed trends that were consistent with those shown in
Table 2. The ‘‘normal fifth percentile’’ was 76% and 72%
predicted for PEF in males and females, respectively, and
within 46–63% for the rest of the indexes.
In the cross-validation of the prediction for FEV1 and FVC,
we calculated the differences and the ratios between
predicted values and observed measurements on the ten
‘validation samples.’ Across the ten ‘validation samples,’
differences (ratios) for FEV1 varied between 0.13 (5%)
and 0.14 l (6%) in females, and between 0.19 (3%) and
0.19l (7%) in males; for FVC they varied between 0.16
(3%) and 0.13l (4%) in females and between 0.24 (4%)
and 0.24l (7%) in males.Comparison with existing reference equations
Figure 2 shows the differences as age varies between
predicted values for FEV1, FVC and VC from the new
equations, and those from ‘Pistelli 2000’, ‘ECCS 1983’ and
‘Hankinson 1999’, separately for normal males and females
of the Pisa study.
Differences were calculated as predicted values for
average subjects derived by the new equations minusdent variables for different volumes and ratios indexes,
FVC FEV1/FVC FEV1/VC
13.18461 0.0213471ns 0.0553481ns
0.2285536 0.0034452ns 0.0013997 ns
0.0036842ns 0.0001494ns 0.0000977ns
0.2355706 0.0116165 0.0120524ns
0.0008819 0.0000359 0.0000362ns
0.1834322 0.00211 0.0023676
0.001246 — —
0.0009158 — —
(20, 24) — —
82 87 88
[79,84] [84,91] [84,90]
4.472363ns 0.1297842ns 0.0454675ns
0.1894842 0.0214414 0.0080805ns
0.0033201 0.0003665 0.0000928ns
s 0.1074871ns 0.0175565 0.0148438ns
0.0004603 0.000057 0.0000489ns
0.155336 0.0022295 0.0024913
0.0016162 — —
0.0010608 — —
(16, 20) — —
83 90 89
[81,85] [87,91] [87,91]
e Appendix.
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Figure 1 Predicted values for average subjects (continuous curves) and observed values (dots) for FEV1 in males (a–c) and in
females (d–f) as age (a, d), height (b, e) and BMI (c, f) vary.
F. Pistelli et al.818predicted values derived by each of the existing equations.
The horizontal line at zero indicates no difference. Curves
above the ‘‘no difference’’ line indicate larger values of the
new equations than those of the comparing equation, while
curves below indicate smaller values.
The new FEV1 predicted values were higher than ‘Pistelli
2000’ until the age of 60 in males and 65 in females, and
lower afterwards. The highest difference was for FEV1
around the age of 20 (about +400ml in males, and +300ml in
females), and for VC over the age of 60 (about–500ml in
males, and 300ml in females).
In both genders, the new predicted values for FEV1, FVC
and VC were nearly always higher than ‘ECCS 1983’ across
the whole age span. The highest difference was for FVC
around the age of 50 (about +500ml in both genders).
Differences with ‘Hankinson 1999’ showed sharp, sudden
changes, since ‘Hankinson 1999’ predictions were obtained
from different equations for different age ranges (stratified
regressions). At age 18, the difference in FEV1 with the new
equations was about +200ml in males and +300ml in
females.
Differences in predictions for FEV1/FVC and FEV1/VC are
shown in Fig. 3. ECCS1 and Hankinson et al.7 did not provide
equations for FEV1/FVC and for FEV1/VC, respectively.
Differences between predicted values calculated according
to the different sets of reference equations also varied along
with different values of BMI and height, for all the indexes
(results not shown).Figures 4–7 present the Bland-Altman plots of the
differences by means, separately by sex, for FEV1, FVC,
FEV1/FVC, and FEV1/VC. Generally, the predicted values
with the new equations tended to be larger than the others,
especially for larger mean values of FEV1 and FVC (Figs. 4
and 5). For FVC, the new equations were more similar to
‘Pistelli 2000’ and ‘Hankinson 1999’, than to ‘ECCS
1983’ (Fig. 5). The latter were steadily lower than the
new equations over the whole range of mean values of both
FEV1 and FVC (Figs. 4 and 5). The predictions for FEV1/FVC
with the new equations were more similar to ‘Hankinson
1999’ than to ‘Pistelli 2000’ (Fig. 6). The predictions for
FEV1/VC were closer to ‘ECCS 1983’ than to ‘Pistelli 2000’
(Fig. 7).Effects on airway obstruction prevalence
To exemplify the relevance of the choice of the reference
equations, we calculated prevalence rates of airway
obstruction on the whole general population samples (i.e.
not only on the ‘‘normal’’ individuals) of Pisa and Po river
delta (Fig. 8). Only adult subjects aged over 24 yr were
included, for they are those who are expected to present
sizable obstruction rates.17 Airway obstruction was defined
according to ERS criterion19: FEV1/VCo0.88 of predicted
value in males and FEV1/VCo0.89 of predicted value in
females. FEV1/VC predicted values were obtained by
ARTICLE IN PRESS
Table 3 Estimated coefficients associated with the independent variables for different flows indexes, separately for the two
genders.
PEF FEF2575% MEF50% MEF75%
Males
Constant 6.123093ns 4.289687ns 1.733825ns 9.499382ns
BMI 0.4512205 0.3887155 0.5291521 0.0882047ns
BMI-squared 0.0080618ns 0.0077062ns 0.010235 0.0024357ns
Height 0.0179494ns 0.0133726ns 0.1029152ns 0.0924414ns
Height-squared 0.0001547ns 0.0001343ns 0.0003808ns 0.0001753ns
Age 0.4269676 0.1779775 0.2273209 0.0606975ns
Spline1(age) 0.0010371 0.0005379 0.0007703 0.0003964
Spline2(age) 0.0004952 0.0002835 0.0004507 0.0002528
(breakpoints) (20, 33) (21, 34) (21, 30) (21, 30)
Normal fifth percentile
(% of predicted) 76 60 61 53
[95% confidence interval] [69,80] [56,68] [57,71] [42,58]
Females
Constant 4.061646ns 1.452058ns 3.194874ns 4.400701ns
BMI 0.0575598ns 0.034093ns 0.0459279ns 0.1503959
BMI2 0.0012472ns 0.0004008ns 0.0009887ns 0.0024881ns
Height 0.0078681ns 0.0178674ns 0.0865969ns 0.0583972ns
Height2 0.0001057ns 0.0001086ns 0.0003046ns 0.0001485ns
Age 0.4885604 0.5601075 0.6128726 0.2876721
Spline1(age) 0.008834 0.0159724 0.0255259 0.0054201
Spline2(age) 0.0029044 0.0039649 0.0169722 0.0024136
(breakpoints) (11, 17) (10, 16) (12, 14) (12, 17)
Normal fifth percentile
(% of predicted) 72 62 63 46
[95% confidence interval] [69,76] [57,67] [60,67] [44,50]
For a numerical example of the computation of predicted values, see Appendix.
nsNon-significant: P40.10 by Wald test.
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Figure 4 Bland-Altman plots for predictions of FEV1 based on the new equations and ‘Pistelli 2000’ (a, d), ‘ECCS 1983’ (b, e), and
‘Hankinson 1999’ (c, f), for males (a–c) and females (d–f).
F. Pistelli et al.820the three European sets of reference equations only, i.e.
the new ones, ‘Pistelli 2000’ and ‘ECCS 1983’. Reference
equations of ‘Hankinson 1999’ were not considered,
as the authors did not provide reference equations for
FEV1/VC.Prevalence rates of airway obstruction largely varied
depending on which reference equation was applied.
Differences between the age-gender-specific prevalence
rates obtained from the new and the existing equations
ranged from 3% to 28%.
ARTICLE IN PRESS
-1
0
1
D
iff
er
en
ce
 in
 F
VC
 (L
)
2 3 4 5 6 7
Mean FVC (L)(a)
-1
0
1
D
iff
er
en
ce
 in
 F
VC
 (L
)
2 3 4 5 6 7
Mean FVC (L)(b)
-1
0
1
D
iff
er
en
ce
 in
 F
VC
 (L
)
2 3 4 5 6 7
Mean FVC (L)(c)
-1
0
1
D
iff
er
en
ce
 in
 F
VC
 (L
)
2 3 4 5 6
Mean FVC (L)(d)
-1
0
1
D
iff
er
en
ce
 in
 F
VC
 (L
)
2 3 4 5 6
Mean FVC (L)(e)
-1
0
1
D
iff
er
en
ce
 in
 F
VC
 (L
)
2 3 4 5 6
Mean FVC (L)(f)
Figure 5 Bland-Altman plots for predictions of FVC based on the new equations and ‘Pistelli 2000’ (a, d), ‘ECCS 1983’ (b, e), and
‘Hankinson 1999’ (c, f), for males (a–c) and females (d–f).
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Figure 6 Bland-Altman plots for predictions of FEV1/FVC % based on the new equations and ‘Pistelli 2000’ (a,c) and ‘Hankinson
1999’ (b,d), for males (a,b) and females (c,d). (ECCS1 did not provide equations for FEV1/FVC.)
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Derivation of new reference equations
We derived reference equations for flow-volume curve
indexes and VC from the 497 ‘‘normal’’ subjects participat-
ing in the second cross-sectional survey of Pisa study in
Central Italy, carried out in 1991–1993. Natural cubic splines
were used to model the nonlinear relationship of the lung
function with age. They provide one single equation for the
entire age range. Differently from multiple equations
derived for age intervals, they provide predicted values
smoothly varying with age, which is without discontinuities
or angled points. As also previously demonstrated,14
reference equations that are continuous and smooth over
the age range may avoid biologically implausible jumps in
predictions associated with consecutive age intervals. On
the contrary, discontinuous equations may yield different
diagnoses for a patient who is examined twice within a short
period of time, who reports the same exact measurements
twice, whose predicted values jump from an age interval to
the next. For sake of completeness, for VC, FVC, and FEV1,
separately in males and females, we estimated two separate
regressions, above and below age 20. Their overall mean
squared error for prediction was almost as good as, never
better than, that of the continuous curves.
Lacking of a validation sample, we performed an internal
cross-validation of the predicted values, separately in males
and females. Overall, the predictions on new, independent
subjects were within 5% to 7%, which appeared reasonably
small. In addition, the means of the ratio of the validation
samples were symmetrically distributed about 100%. Such
variability in each sample was expected, since the predic-
tion, conditional on sex, age, height and BMI, is an estimate
of the population conditional mean. Each individual may
differ from the population mean. Even if the model we
estimated was perfectly true, we would see a residual error
in the individual prediction, which is often known as
variability of the individual forecast.
Along with age and height, BMI was also introduced as
independent variable in the reference equations. BMI is also
included among independent variables in reference equa-
tions for arterial oxygen tension24 and the 6-min walking
test in healthy adults.25 BMI proved to be a significant
predictor that improved prediction capabilities, as also
noted for the equations we derived on a rather different
population.14 Contrarily, BMI was considered but not
included among independent variables in other reference
equations.7 From our findings, BMI appears to be an
important predictor of lung function both in youth, where
it provides a proxy to body growth, not fully explained by
age and height alone, and in adults, where it accounts for
differences in physical complexion and obesity.26 In our
data, there is no evidence that, on average, the effect of
BMI on lung function is not smooth over time; there is no
clear cut-off age at which this effect may change. Indeed,
the age of transition from childhood to adulthood varies
naturally across different individuals. Setting a cut-off value
to split the age range in childhood/adolescence and
adulthood would be necessarily arbitrary and detrimental
to the accuracy of the prediction. Also, as shown by Bottai
et al.27 variations of lung function in adults over time areinfluenced by variations of BMI, independently of age,
smoking habits, respiratory symptoms and diseases, and
other individual characteristics.
As also noted elsewhere,15 the lung vital capacity may
differ whether measured by the slow (VC) or forced
expiration (FVC) maneuvers, VC being usually higher than
FVC. By using a pneumotachograph, we found FVC higher
than VC in 35% and 36%, for males and females respectively,
among 1185 longitudinal observations provided by 1039
‘‘normal’’ subjects on which the ‘Pistelli 2000’ equations
were derived.14 In the present sample, by using a water
sealed spirometer, we observed a not negligible proportion
of individuals with FVC greater than VC (58% in males, 50% in
females). On average, FVC was 3% higher than VC in males
and 2% in females, i.e. values within the threshold of
acceptable variability (5%),2 as described in the section
‘Material and methods’. These results may be accounted for
by instrument characteristics, measurement procedures and
inter- or intra-individual variability. For sake of complete-
ness, we also reported the summary statistics of the
individual maximum value between VC and FVC (VCmax).
It is to point out that, the lower confidence limits for
volumes and ratios, below which lung function is considered
abnormal, were almost identical for the Pisa study and the
Po river delta study and the same as those indicated by ERS
to define airway obstruction.19Comparison with existing reference equations
We compared the new equations with those of ‘Pistelli
2000’, ‘ECCS 1983’ and ‘Hankinson 1999’, on the whole
sample of ‘‘normal’’ subjects from Pisa study. Differences
among the equations for FEV1, FVC, VC and their ratios were
quantified for average subjects. Bland-Altman plots were
produced as additional visual comparison. These equations
were chosen, among several others, because the former
were derived from another Italian population sample by
using the same statistical model as the one used for the new
equations, while the latter two equations are the most
commonly used equations in lung function laboratories in
Europe and United States.
Different predicted values between the new and ‘Pistelli
2000’ equations can be imputed to the joint effects of
several factors: different areas (urban vs. rural), different
cohorts (cross-sectional sample—survey time 1991–1993 vs.
pooled cross sectional and longitudinal samples—survey
time 1980–1982 and 1988–1991), different technicians and
different instruments used (water sealed spirometer vs.
pneumotachograph).28,29
It is known30,31 that the spirometer generally tends to
underestimate lung volumes when compared to the pneu-
motachograph. A small study, comparing three different
instruments on the same four subjects,32 reported that the
water sealed spirometer used in the present study provides
smaller measurements of FEV1, FVC and VC and higher
values of FEV1/FVC and FEV1/VC ratios than the pneumota-
cograph used in the previous study.14 The same instrument
used in the present study was utilized in many centres
participating in the European Community Respiratory Health
Survey.6 Within the study conducted to derive spirometric
reference equations from that population, a specific
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F. Pistelli et al.824comparison among instruments used in the various partici-
pating centres was not performed.6
Consistently with other reference equations derived from
younger cohorts of European populations,6,8,13,15 the new
equations appeared to provide higher predictive values than
‘ECCS 1983’. The new equations differ from ‘ECCS 1983’
mostly for the materials and methods used, since the latter
were based on published regression equations—instead of
the original data—from older surveys (published between
1950s and 1980s), which employed different instruments.
Besides, they did not include BMI.
‘Hankinson 1999’ equations7 for Caucasians were based
on an age range similar to the new equations. The
instrument used was a dry rolling-seal spirometer. Regres-
sion models stratified by age groups were used instead of
smooth equations. Differences between the predictions can
be primarily, although not exclusively, attributed to the
different methods applied (stratified regressions vs. smooth
equations) and the populations studied.
Overall, differences among the predicted values of
different equations remarkably varied over the range of
values of age, height and BMI. Although the reference
equations considered were derived from populations that
differed with respect to age, height and BMI, these
characteristics were accounted for in the models, and
cannot explain the differences in the predictions.Effects on airway obstruction prevalence
It seems that using equations that are not population-
specific and instrument-specific (i.e. the new ones for the Po
river delta sample and ‘Pistelli 2000’ for the Pisa sample)
may lead to biased estimates of prevalence. It also appears
that the use of summary equations, such as the ‘ECCS 1983’,
may not be appropriate for all possible populations. Indeed,
the ‘ECCS 1983’ provided rates that were closer to the new
ones but very different from ‘Pistelli 2000’.
It should be noted that the lower limit of normal vary
across different reference equations. The use of one unique
lower limit of normal should be discouraged in the clinical
settings, as recently recommended by ATS/ERS Task Force
on the standardisation of lung function testing,3 which
defines airways obstruction as a reduced FEV1/VC
ratio below the fifth percentile of the predicted
value.Conclusions
According to current recommendations from ATS/ERS Task
Force on the standardisation of lung function testing,3 as
well as other recent reports,11–13 our results reinforce the
need of applying reference equations derived from samples
of ‘‘normals’’ who are as similar as possible to the study
subject/population on which such equations are applied,
and based on measurements obtained by the same instru-
ments and protocols. Variations in time, space, instruments
or population characteristics may result in biased predic-
tions. Therefore it would be recommendable that such
information be reported in detail whenever new reference
equations are provided. Finally, our results confirm the needof periodically updating reference equations for lung
function.
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Appendix A. Natural cubic splines regression
models
The age span was split into three phases of lung function
(growth, plateau, and decline) by means of two breakpoints.
The regression model for the expected value of any lung
function index was:
b0 þ b1BMIþ b2BMI2 þ b3heightþ b4height2 þ b5age
þ b6Spline1ðageÞ þ b7 Spline 2ðageÞ;
where bs are parameters to be estimated, and Spline1(  ) and
Spline2(  ) are natural cubic splines computed as follows:
SplinejðageÞ ¼
ðage 8Þ3  ð74 breakpointjÞ
ð74 8Þ
þ ðage breakpointjÞ3  IðageXbreakpointjÞ,
where j ¼ 1, 2, and I(A) denotes the indicator function that
equals one if A is true and zero otherwise; Spline1(  ) and
Spline2(  ) were computed considering that the age range in
the sample was 8–74yr in females. The two breakpoints were
different for each regression model and were estimated to
maximize the goodness-of-fit in terms of R2.
Example: calculation of predicted values for FEV1
To exemplify the use of the estimated coefficients shown in
Table 2, suppose we want to compute the predicted FEV1
value for a man aged 32 yr whose height and weight are
168 cm and 57 kg, respectively. Then, we compute
BMI ¼ 57=1:682 ¼ 20:195578 kg=m2,
Spline1ð32Þ ¼ ð32 8Þ3ð70 21Þ=ð70 8Þ þ ð32 21Þ3
¼ 9770:0909,
Spline2ð32Þ ¼ ð32 8Þ3ð70 25Þ=ð70 8Þ þ ð32 25Þ3
¼ 9920:2727.
From the coefficients reported in Table 2,
FEV1 predicted ¼ 5:43862þ 0:1918785 ð20:195578Þ
 0:0034633 ð20:195578Þ2
 0:1241893 ð168Þ þ 0:0005119 ð168Þ2
þ 0:1603364 ð32Þ þ 0:0011688 ð9770:0909Þ
 0:0008873 ð9920:2727Þ ¼ 4:00 l:
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within the ranges observed in our samples as shown in the
following table (also shown in Table 1).Age (yr) BMI (kg/m2) Height (cm)Males 8–70 14.57–34.26 125–195
Females 8–74 14.72–39.74 125–181References
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